SG11201909689TA - Method and system for monitoring a diabetes treatment plan - Google Patents
Method and system for monitoring a diabetes treatment planInfo
- Publication number
- SG11201909689TA SG11201909689TA SG11201909689TA SG11201909689TA SG 11201909689T A SG11201909689T A SG 11201909689TA SG 11201909689T A SG11201909689T A SG 11201909689TA SG 11201909689T A SG11201909689T A SG 11201909689TA
- Authority
- SG
- Singapore
- Prior art keywords
- alc
- patient
- predicted
- international
- monitoring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/06—Buying, selling or leasing transactions
- G06Q30/0601—Electronic shopping [e-shopping]
- G06Q30/0631—Recommending goods or services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Data Mining & Analysis (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Databases & Information Systems (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Signal Processing (AREA)
- Artificial Intelligence (AREA)
- Business, Economics & Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Pharmacology & Pharmacy (AREA)
- Economics (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2017/050753 WO2018232487A1 (fr) | 2017-06-20 | 2017-06-20 | Procédé et système de surveillance d'un plan de traitement du diabète à |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201909689TA true SG11201909689TA (en) | 2019-11-28 |
Family
ID=64736237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201909689T SG11201909689TA (en) | 2017-06-20 | 2017-06-20 | Method and system for monitoring a diabetes treatment plan |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11793471B2 (fr) |
| EP (1) | EP3642789A4 (fr) |
| AU (1) | AU2017420200A1 (fr) |
| CA (1) | CA3064598A1 (fr) |
| SG (1) | SG11201909689TA (fr) |
| WO (1) | WO2018232487A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3839963A1 (fr) * | 2019-12-20 | 2021-06-23 | Digital Diabetes Analytics Sweden AB | Système d'analyse du diabète et procédé en relation avec le système |
| JP7471094B2 (ja) * | 2020-01-30 | 2024-04-19 | キヤノンメディカルシステムズ株式会社 | 学習支援装置及び方法 |
| WO2022050992A1 (fr) * | 2020-09-02 | 2022-03-10 | Twin Health, Inc. | Surveillance virtuelle des taux de glucose chez un patient faisant appel à une technologie d'apprentissage machine et à une technologie de jumeau numérique |
| US20220088303A1 (en) * | 2020-09-21 | 2022-03-24 | Insulet Corporation | Techniques for determining automated insulin delivery dosages |
| CN113876320B (zh) * | 2021-09-29 | 2024-06-25 | 天津用恒医疗科技有限公司 | 血红蛋白浓度确定方法、装置、电子设备和存储介质 |
| WO2024211880A2 (fr) * | 2023-04-07 | 2024-10-10 | Bigfoot Biomedical, Inc. | Procédé de gestion pour une thérapie à l'insuline à l'aide de voies d'apprentissage par renforcement et d'augmentation de thérapie |
| WO2024259265A2 (fr) * | 2023-06-14 | 2024-12-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Systèmes et procédés de modélisation et de simulation de réponse glycémique pour des interventions sur le style de vie comportemental |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI112545B (fi) | 1997-05-30 | 2003-12-15 | Nokia Corp | Menetelmä ja järjestelmä potilaan veren glykosyloidun hemoglobiinikomponentin tason ennustamiseksi |
| US6277071B1 (en) | 1999-06-25 | 2001-08-21 | Delphi Health Systems, Inc. | Chronic disease monitor |
| PL198154B1 (pl) * | 2000-03-29 | 2008-05-30 | Univ Virginia | Sposób kontroli HbA₁c pacjenta w oparciu o dane stężenia glukozy we krwi, sposób oceny hipoglikemii u pacjenta i urządzenie do kontroli cukrzycy u pacjenta |
| ATE392178T1 (de) * | 2000-08-18 | 2008-05-15 | Animas Technologies Llc | Vorrichtung zum vorhersagen von hypoglyecemiefällen |
| ES2456068T3 (es) | 2002-08-13 | 2014-04-21 | University Of Virginia Patent Foundation | Método, sistema y producto de programa informático para el procesamiento de datos de auto-supervisión de glucemia (SMBG) para mejorar la autogestión diabética |
| US7824333B2 (en) * | 2006-03-31 | 2010-11-02 | Lifescan, Inc. | Diabetes management methods and systems |
| US20100145174A1 (en) * | 2008-02-12 | 2010-06-10 | Alferness Clifton A | System And Method For Providing A Personalized Tool For Estimating Glycated Hemoglobin |
| US20100198021A1 (en) | 2008-02-12 | 2010-08-05 | Alferness Clifton A | Computer-implemented method for providing a tunable personalized tool for estimating glycated hemoglobin |
| US8924159B2 (en) * | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| US8591410B2 (en) * | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| US20100330598A1 (en) | 2009-06-26 | 2010-12-30 | Roche Diagnostics Operations, Inc. | METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR PROVIDING BOTH AN ESTIMATED TRUE MEAN BLOOD GLUCOSE VALUE AND ESTIMATED GLYCATED HEMOGLOBIN (HbA1C) VALUE FROM STRUCTURED SPOT MEASUREMENTS OF BLOOD GLUCOSE |
| US20120253840A1 (en) * | 2009-12-21 | 2012-10-04 | Stc.Unm | System and methods for estimating hba1c, treatment response, and hypoglycemia risk using self-monitoring of blood glucose data |
| ES2962508T3 (es) | 2011-01-31 | 2024-03-19 | Hoffmann La Roche | Visualización de valores biológicos |
| JP5997453B2 (ja) * | 2011-04-25 | 2016-09-28 | アークレイ株式会社 | 情報処理装置およびユーザ端末 |
| AU2014218785A1 (en) | 2013-02-21 | 2015-09-10 | University Of Virginia Patent Foundation | Tracking changes in average glycemia in diabetics |
| CA3027019C (fr) | 2015-06-08 | 2023-10-03 | University Of Virginia Patent Foundation | Systeme et procede de suivi des changements de glycemie moyenne chez des diabetiques |
| US9886556B2 (en) | 2015-08-20 | 2018-02-06 | Aseko, Inc. | Diabetes management therapy advisor |
-
2017
- 2017-06-20 WO PCT/CA2017/050753 patent/WO2018232487A1/fr not_active Ceased
- 2017-06-20 SG SG11201909689T patent/SG11201909689TA/en unknown
- 2017-06-20 AU AU2017420200A patent/AU2017420200A1/en not_active Abandoned
- 2017-06-20 CA CA3064598A patent/CA3064598A1/fr active Pending
- 2017-06-20 EP EP17914963.8A patent/EP3642789A4/fr not_active Withdrawn
- 2017-06-20 US US16/616,367 patent/US11793471B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017420200A1 (en) | 2020-01-16 |
| US20200121257A1 (en) | 2020-04-23 |
| EP3642789A4 (fr) | 2021-01-27 |
| CA3064598A1 (fr) | 2018-12-27 |
| EP3642789A1 (fr) | 2020-04-29 |
| WO2018232487A1 (fr) | 2018-12-27 |
| US11793471B2 (en) | 2023-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909689TA (en) | Method and system for monitoring a diabetes treatment plan | |
| SG11201407747QA (en) | A method and apparatus for facilitating the management of health and security | |
| SG11201810221YA (en) | Fidelity estimation for quantum computing systems | |
| SG11201408002TA (en) | Multi-parameter diabetes risk evaluations | |
| SG11201900752PA (en) | Cybersecurity vulnerability management system and method | |
| SG11201808475XA (en) | Method and apparatus for providing a pharmacokinetic drug dosing regiment | |
| SG11201804643PA (en) | Indicator device | |
| SG11201408383SA (en) | Methods of detecting diseases or conditions using circulating diseased cells | |
| SG11201407508RA (en) | Encoding and decoding based on blending of sequences of samples along time | |
| SG11201903928WA (en) | Mesenchymal stem cells populations, their products, and use thereof | |
| SG11201407459QA (en) | System and method for predicting the immunogenicity of a peptide | |
| SG11201806861SA (en) | Combination therapy with anti-cd73 antibodies | |
| SG11201408261UA (en) | Syringe | |
| SG11201407860PA (en) | Exendin-4 peptide analogues | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
| SG11201407803TA (en) | Nmr measurements of glyca | |
| SG11201809605PA (en) | Compositions for and method of treating acid-base disorders | |
| SG11201807719SA (en) | Use of clinical parameters for the prediction of sirs | |
| SG11201408434QA (en) | Targeted rna-seq methods and materials for the diagnosis of prostate cancer | |
| SG11201408808WA (en) | Method and system for treatment of biological tissue | |
| SG11201807306XA (en) | Uniqueness level for anonymized datasets | |
| SG11201811550XA (en) | Demand prediction for time-expiring inventory | |
| SG11201408037SA (en) | Humanized anti-trka antibodies with amino acid substitutions | |
| SG11201809749VA (en) | Computer systems and methods for implementing in-memory data structures |